1. TCF7L2: the biggest story in diabetes genetics since HLA?

   • E. Zeggini
   • M. I. McCarthy

   Commentary Open access 10 November 2006 Pages: 1 - 4

2. TCF7L2 and type 2 diabetes—we WNT to know

   • U. Smith

   Commentary 11 November 2006 Pages: 5 - 7

   

3. Peroxisome proliferator-activated receptor-δ, a regulator of oxidative capacity, fuel switching and cholesterol transport

   • C. Fürnsinn
   • T. M. Willson
   • B. Brunmair

   Review 22 November 2006 Pages: 8 - 17

   

4. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study

   • L. Prompers
   • M. Huijberts
   • N. Schaper

   Article 09 November 2006 Pages: 18 - 25

   

5. Impact of diabetes on haemoglobin levels in renal disease

   • R. Ravanan
   • J. R. Spiro
   • R. M. Smith

   Article 28 November 2006 Pages: 26 - 31

   

6. Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine

   • A. M. Vaiserman
   • B. Carstensen
   • L. V. Mechova

   Short Communication 09 November 2006 Pages: 32 - 35

   

7. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study

   • R. C. Hoogeveen
   • C. M. Ballantyne
   • J. S. Pankow

   Article 29 November 2006 Pages: 36 - 42

   

8. Relationships of maternal and paternal birthweights to features of the metabolic syndrome in adult offspring: an inter-generational study in South India

   • S. R. Veena
   • S. Geetha
   • C. H. D. Fall

   Article 02 December 2006 Pages: 43 - 54

   

9. Age, overweight and physical inactivity increase the risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag health study

   • S. Carlsson
   • K. Midthjell
   • V. Grill

   Short Communication 10 November 2006 Pages: 55 - 58

10. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort

    • J. V. van Vliet-Ostaptchouk
    • R. Shiri-Sverdlov
    • C. Wijmenga

    Short Communication 10 October 2006 Pages: 59 - 62

11. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population

    • G. R. Chandak
    • C. S. Janipalli
    • C. S. Yajnik

    Short Communication 09 November 2006 Pages: 63 - 67

12. An association analysis of the HLA gene region in latent autoimmune diabetes in adults

    • M. Desai
    • E. Zeggini
    • A. Clark

    Short Communication 02 December 2006 Pages: 68 - 73

13. Enhanced mitochondrial metabolism may account for the adaptation to insulin resistance in islets from C57BL/6J mice fed a high-fat diet

    • M. Fex
    • M. Dekker Nitert
    • H. Mulder

    Article 09 November 2006 Pages: 74 - 83

    

14. Increasing uncoupling protein-2 in pancreatic beta cells does not alter glucose-induced insulin secretion but decreases production of reactive oxygen species

    • N. Produit-Zengaffinen
    • N. Davis-Lameloise
    • F. Assimacopoulos-Jeannet

    Article 28 November 2006 Pages: 84 - 93

    

15. Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration

    • S. Krapivner
    • E. Chernogubova
    • F. M. van ’t Hooft

    Article 15 November 2006 Pages: 94 - 102

    

16. Substrate source utilisation in long-term diagnosed type 2 diabetes patients at rest, and during exercise and subsequent recovery

    • H. Boon
    • E. E. Blaak
    • L. J. C. van Loon

    Article 28 November 2006 Pages: 103 - 112

    

17. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects

    • V. B. Schrauwen-Hinderling
    • M. E. Kooi
    • P. Schrauwen

    Article 09 November 2006 Pages: 113 - 120

    

18. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach

    • A. Fodor
    • C. Harel
    • E. Karnieli

    Article 28 November 2006 Pages: 121 - 130

    

19. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice

    • Y. Tamura
    • T. Ogihara
    • H. Watada

    Article 09 November 2006 Pages: 131 - 141

    

20. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

    • S. L. Conarello
    • G. Jiang
    • B. B. Zhang

    Article 28 November 2006 Pages: 142 - 150

    

21. Committed subcutaneous preadipocytes are reduced in human obesity

    • Y. Tchoukalova
    • C. Koutsari
    • M. Jensen

    Article 10 November 2006 Pages: 151 - 157

    

22. β₂-Adrenergic activation increases glycogen synthesis in L6 skeletal muscle cells through a signalling pathway independent of cyclic AMP

    • D. L. Yamamoto
    • D. S. Hutchinson
    • T. Bengtsson

    Article 22 November 2006 Pages: 158 - 167

    

23. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity

    • P. D. Mountjoy
    • S. J. Bailey
    • G. A. Rutter

    Article 09 November 2006 Pages: 168 - 177

    

24. The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes

    • R. E. Warren
    • N. N. Zammitt
    • B. M. Frier

    Article 02 December 2006 Pages: 178 - 185

    

25. QT_c interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up

    • C. Stettler
    • A. Bearth
    • P. Diem

    Article 10 November 2006 Pages: 186 - 194

    

26. Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes

    • L. Sauma
    • N. Franck
    • F. H. Nystrom

    Article 15 November 2006 Pages: 195 - 201

    

27. Increased blood–brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases

    • B. T. Hawkins
    • T. F. Lundeen
    • R. D. Egleton

    Article 02 December 2006 Pages: 202 - 211

    

28. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects

    • S. F. Field
    • J. M. M. Howson
    • J. A. Todd

    Research Letter 25 October 2006 Pages: 212 - 213

29. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects

    • S. Cauchi
    • M. Vaxillaire
    • P. Froguel

    Research Letter 09 November 2006 Pages: 214 - 216

    

30. Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: the relationship with ATP binding cassette proteins G5 and G8 and Niemann–Pick C1-like 1 mRNA

    • S. E. Lally
    • D. Owens
    • G. H. Tomkin

    Letter 11 November 2006 Pages: 217 - 219

    

31. Comment on: Brugman S et al. (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105–2108

    • R. F. Schwartz
    • J. Neu
    • C. Wasserfall

    Letter 21 November 2006 Pages: 220 - 221

    

32. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721

    • P. E. Cryer

    Letter 20 September 2006 Pages: 222 - 224

33. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49: 1711–1721

    • B. Schultes

    Letter 22 September 2006 Pages: 225 - 226

34. Comment on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes:a consensus algorithm for the initiation and adjustmentof therapy. A consensus statement from the American Diabetes Association and the European Associationfor the Study of Diabetes. Diabetologia 49:1711–1721

    • M. Porta
    • M. Trento

    Letter 28 October 2006 Pages: 227 - 228

35. Comment on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49: 1711–1721

    • T. Takamura
    • A. Shimizu
    • S. Kaneko

    Letter 23 November 2006 Pages: 229 - 230

36. Response to comments on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721

    • D. M. Nathan
    • for the Consensus Group

    Letter - author's response 14 November 2006 Pages: 231 - 233

37. Comment on: Schmidt MI, Duncan BB, Vigo A et al (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096

    • M. B. Snijder
    • J. M. Dekker
    • J. C. Seidell

    Letter 11 October 2006 Pages: 234 - 236

38. Response to comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096

    • M. I. Schmidt
    • B. B. Duncan
    • for the ARIC Investigators

    Letter 09 November 2006 Pages: 237 - 238

    

39. Comment on: Schmidt MI, Duncan BB, Vigo A et al. (2006) Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086–2096

    • J. R. S. Arch

    Letter 10 November 2006 Pages: 239 - 240

40. Comment on: Tseng C-H, Tseng C-P, Chong C-K et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760

    • T. H.-H. Chen
    • B. J. Boucher

    Letter 27 October 2006 Pages: 241 - 241

41. Response to comment on: Tseng C-H, Tseng C-P, Chong C-K et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760

    • C.-H. Tseng

    Letter 28 November 2006 Pages: 242 - 243

42. Type 2 diabetes and cardiovascular risk in the UK south Asian community

    • A. H. Barnett
    • A. N. Dixon
    • S. Kumar

    Erratum 09 November 2006 Pages: 244 - 244

43. List of Referees

    List of Referees 20 December 2006 Pages: 245 - 246